The Drug Regulatory Authority of Pakistan (DRAP) has banned the sale and use of five batches of auto-disable syringes manufactured by three companies after they were found to be substandard.
According to a medical product alert issued by the authority, the affected syringes failed the auto-disable test, raising concerns that they could be reused.
DRAP warned that the reuse of syringes poses a serious public health risk and can lead to the spread of dangerous diseases, including hepatitis and HIV.
The action comes amid an ongoing crackdown against substandard auto-disable syringes across the country. Some syringes available in Karachi markets have also been declared substandard.
DRAP said the Central Drug Laboratory in Karachi recommended declaring three syringe samples substandard after testing. The companies named in the alert are based in Lahore, Peshawar, and Swabi.
The affected products include one batch of Surgi Plast Swabi’s “Clinic Auto Disable Syringe,” batch AD1B25 of Frontier Pharmaceuticals Peshawar’s “Medi Aqua Auto Syringe,” and two batches of Sehat Medical Devices Lahore’s “Ultra Fine Auto Syringe.”
According to the alert, faults in the auto-disable system mean the syringes may not lock after use, creating the risk of reuse.
DRAP has instructed all provincial drug control authorities to take immediate action to halt the sale and use of the affected batches. The authority has also ordered officials to confiscate the substandard syringes currently available in the market.
Manufacturers, importers, and distributors have also been instructed to immediately recall the affected batches from the market.
Get the latest news and stories wherever you prefer.
Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.
Shares
